Biocept (BIOC) Reports Q3 Loss of $2.42/Share

Biocept (NASDAQ: BIOC) reported Q3 EPS of ($2.42), versus ($5.90) reported last year. Revenue for the quarter came in at $762 thousand, versus $1.1 million reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• South Plains Financial Inc. (SPFI) Tops Q2 EPS by 1c
• Cohen & Steers (CNS) Tops Q2 EPS by 2c